Skip to Content
Surgical Director, Kidney and Living Donor Transplant ProgramAssistant Professor, Division of Transplant and HPB SurgeryAssistant Professor of Surgery - Transplantation and Hepatobiliary Surgery
Primary Office: SE420 GHIowa City, IA 52242 Primary Office Phone: 319-384-5494
Email: zoe-stewart@uiowa.edu
BS, Biology/Chemistry, University of TulsaPhD, Biochemistry, Vanderbilt School of MedicineMD, Vanderbilt School of Medicine
Halsted Surgical Internship, General Surgery, Johns Hopkins HospitalResidency, General Surgery, Halsted, Johns Hopkins HospitalFellowship, Abdominal Transplant Surgery, Johns Hopkins Hospital
Certified, Advanced Trauma Life SupportAdvanced Cardiac Life Support (ACLS)Board Certified, American Board of Surgery
Dr. Stewart conducts epidemiologic studies of ABO incompatible liver transplant analysis, Liver/pancreas/kidney graft survival after preservation with HTK versus UW, and Hepatic artery thrombosis analysis/risk stratification.
Show All
Hepatitis C Positive Simultaneous Liver-Kidney Recipients Have Significantly Reduced Early Post-Transplant Survival. . Stewart Z, Collins T, Reed A, Segev D. 2011. Novel Therapeutic Strategies for Treatment of Rapidly Recurrent FSGS Post-Transplant. Stewart Z, Shetty R, Reed A, Myers D, Brophy . 2011. Current utilization of preservation solutions and protocols for abdominal procurements: results of a national survey of Organ Procurement Organizations (OPOs). . Stewart Z, Collins , Katz D, Reed A, Segev D. 2010. Era effect of histidine-tryptophan-ketoglutarate (HTK) preservation on abdominal allograft survival.. Stewart Z, Collins T, Katz D, Reed , Segev D. 2010. ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation. Stewart Z, Montgomery R, Locke J, King K, Segev D, Cooper M, Simpkins C, Melancon J, Haas M, Zachary A, Warren D, Ratner L, Singer A, Kraus E. 2009; 87 (8) :1246-55. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Stewart Z, Locke J, Montgomery R, Singer A, Cameron A, Segev D. 2009; 15 (8) :888-93. Advanced donor age is associated with increased biliary complications after donation after cardiac death. Stewart Z, Singh , Mascarenhas R, Krishnamurthy D, Singer , Gurakar , Cameron A. 2009. Giant Brunner’s gland hamartoma: case report and literature review. Stewart Z, Fishman E, Hruban R, Wolfgang C. 2009; 2 (7) :68. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Stewart Z, Cameron , Singer A, Montgomery R, Segev D. 2009. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor kidney transplants. Stewart Z, Cameron A, Singer A, Montgomery , Segev D. 2009.
Date Last Modified: 01/08/2013 - 17:05:00